501Y.V2 and 501Y.V3 variants of SARS-CoV-2 lose binding to bamlanivimab in vitro
The newly emerging variants of SARS-CoV-2 from South Africa (B.1.351/501Y.V2) and Brazil (P.1/501Y.V3) have led to a higher infection rate and reinfection of COVID-19 patients. We found that the mutations K417N, E484K, and N501Y within the receptor-binding domains (RBDs) of the virus could confer ~2...
Saved in:
Main Authors: | Haolin Liu (Author), Pengcheng Wei (Author), Qianqian Zhang (Author), Zhongzhou Chen (Author), Katja Aviszus (Author), Walter Downing (Author), Shelley Peterson (Author), Lyndon Reynoso (Author), Gregory P. Downey (Author), Stephen K. Frankel (Author), John Kappler (Author), Philippa Marrack (Author), Gongyi Zhang (Author) |
---|---|
Format: | Book |
Published: |
Taylor & Francis Group,
2021-01-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
The new SARS-CoV-2 strain shows a stronger binding affinity to ACE2 due to N501Y mutant
by: Fedaa Ali, et al.
Published: (2021) -
Effect of the N501Y Mutation on Ligands Complexed with SARS-CoV-2 RBD: Insights on Potential Drug Candidates for COVID-19
by: Camila Fonseca Amorim da Silva, et al.
Published: (2023) -
Outcomes of infants with birthweights less than 501 g compared to infants weighing 501-750 g at a center utilizing first intention high frequency jet ventilation
by: Timothy G. Elgin, et al.
Published: (2024) -
Correction to Lancet Glob Health 2017; 5: e501-11
Published: (2018) -
Insights into the Adsorption Mechanisms of the Antimicrobial Peptide CIDEM-501 on Membrane Models
by: Daniel Alpízar-Pedraza, et al.
Published: (2024)